Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|November 14, 1997
Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literatureA V Cayco, M A Perazella, J P HayslettConnecticut Medicine|February 1, 1996
Mechanical mitral valve prosthesis dysfunction from thrombus: transesophageal echocardiography has limitationsM A Perazella, W Frederick, G K Buller, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1993
Renal failure and severe hypokalemia associated with acute myelomonocytic leukemiaM A Perazella, R N Eisen, W G Frederick, et al.Annals of Internal Medicine|August 15, 1993
Renal mechanism of trimethoprim-induced hyperkalemiaH Velázquez, M A Perazella, F S Wright, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 23, 1999
Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotensionD N Cruz, R L Mahnensmith, H M Brickel, et al.Clinical Nephrology|November 19, 2010
Experience with outpatient computed tomographic-guided renal biopsyA Margaryan, M A Perazella, R L Mahnensmith, et al.Clinical Nephrology|September 2, 1998
Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-upD N Cruz, R L Mahnensmith, H M Brickel, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 7, 2001
Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool DialysateR Alappan, D Cruz, A K Abu-Alfa, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1996
Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?D N Cruz, M A Perazella, A K Abu-Alfa, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 1998
Reduction in arteriovenous graft impairment: results of a vascular access surveillance protocolA V Cayco, A K Abu-Alfa, R L Mahnensmith, et al.Pageof 6